Levosalbutamol sulphate

硫酸左沙丁胺醇

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLevosalbutamol sulphate
Drug Alias NameLevosalbutamol sulfateLevolinASF-1096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsLupus Erythematosus, DiscoidLupus Erythematosus, CutaneousAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmark
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstion Pharma
China Registration ClassN/A

Develop Information

Inactive CompaniesAstion Pharma A/S
Active IndicationsLupus Erythematosus, DiscoidLupus Erythematosus, CutaneousAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03ACR03CC